"Fakultní nemocnice Ostrava je největším státním zdravotnickým zařízením na severní Moravě. Zajišťuje zdravotní péči pro 1, 2 mil. obyvatel. Ročně je na 1 100 lůžkách hospitalizováno v průměru více než 46 000 pacientů, přičemž více než 50 % tvoří pacienti se závažnou či komplikovanou diagnózou. Ambulantně je v nemocnici provedeno ročně téměř 600 000 ambulantních ošetření. Významným rysem nemocnice je její maximální komplexnost, spočívající v šíři a hloubce postupu od primární diagnostiky přes léčbu až k následné ambulantní či doléčovací péči. Naše fakultní nemocnice je špičkovou nemocnicí a zaujímá přední místo mezi zdravotnickými zařízeními nejvyššího typu v České republice. Její renomé je známo a uznáváno také v zahraničí."

During the past decade, Fakultni nemocnice Ostrava conducted 229 clinical trials. In the 10-year time frame, 229 clinical trials started and 70 clinical trials were completed, i.e. on average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 117 clinical trials started and 52 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultni nemocnice Ostrava" #1 sponsor was "University Hospital Ostrava" with 86 trials, followed by "Janssen Research & Development, LLC" with 15 trials sponsored, "Bayer" with 11 trials sponsored, "Hoffmann-La Roche" with 11 trials sponsored and "Boehringer Ingelheim" with 11 trials sponsored. Other sponsors include 157 different institutions and companies that sponsored additional 96 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice Ostrava" #1 collaborator was "University of Ostrava" with 10 trials as a collaborator, "University Hospital Ostrava" with 5 trials as a collaborator, "Palacky University" with 4 trials as a collaborator, "Gynecologic Oncology Group" with 3 trials as a collaborator and "Janssen Research & Development, LLC" with 3 trials as a collaborator. Other collaborators include 123 different institutions and companies that were collaborators in the rest 110 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Ostrava" are "Multiple Myeloma" (24 trials), "Ovarian Cancer" (7 trials), "Chronic Lymphocytic Leukemia" (6 trials), "Ulcerative Colitis" (6 trials) and "Multiple Sclerosis" (5 trials). Many other conditions were trialed in "Fakultni nemocnice Ostrava" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice Ostrava" are "Drug" (188 trials), "Procedure" (47 trials), "Other" (30 trials), "Device" (22 trials) and "Diagnostic Test" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Dexamethasone" (22 trials), "Daratumumab" (12 trials), "Lenalidomide" (11 trials) and "Bortezomib" (10 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice Ostrava" are 278 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 118 active trials in "Fakultni nemocnice Ostrava". 4 are not yet recruiting, 58 are recruiting, 53 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 144 completed trials in Fakultni nemocnice Ostrava, undefined suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice Ostrava, 14 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 60 trials that are defined as “Not Applicable".

Fakultni nemocnice Ostrava has several departments that took part in Clinical trials: "Fakultni nemocnice Ostrava, Neurologická klinika" - 2 trials